IPAD-DB ID | D01389 |
Name | RS-0406 |
Category | Drugs |
2D Structure |
|
3D Structure | |
Molecular Formula | C 1 6 H 1 4 N 4 O 2 |
Molecular Weight | 294.31 g/mol |
IUPAC Name | 3-[[6-(3-hydroxyanilino)pyridazin-3-yl]amino]phenol |
InChI | InChI=1S/C16H14N4O2/c21-13-5-1-3-11(9-13)17-15-7-8-16(20-19-15)18-12-4-2-6-14(22)10-12/h1-10,21-22H,(H,17,19)(H,18,20) |
InChIKey | GYNDFOLSPPBBIK-UHFFFAOYSA-N |
Canonical SMILES | C1=CC(=CC(=C1)O)NC2=NN=C(C=C2)NC3=CC(=CC=C3)O |
PubChem CID | 9882580 |
DrugBank Accession Number | - |
CAS Registry Number | 530112-00-6 |
Molecular Weight(Computed by SwissADME) | 294.31 |
Hac(Computed by SwissADME) | 22 |
Volume(Computed by ADMETlab 2.0) | 297.462 |
Density(Computed by ADMETlab 2.0) | 0.989 |
nRing(Computed by ADMETlab 2.0) | 3 |
MaxRing(Computed by ADMETlab 2.0) | 6 |
nHet(Computed by ADMETlab 2.0) | 6 |
fChar(Computed by ADMETlab 2.0) | 0 |
nRig(Computed by ADMETlab 2.0) | 20 |
Flexibility(Computed by ADMETlab 2.0) | 0.1 |
Stero Centers(Computed by ADMETlab 2.0) | 0 |
LogS(Computed by ADMETlab 2.0) | -2.59 |
LogD(Computed by ADMETlab 2.0) | 3.118 |
logP(Computed by ADMETlab 2.0) | 3.004 |
TPSA(Computed by SwissADME) | 90.3 |
Hbond Acceptor(Computed by SwissADME) | 4 |
Hbond Donor(Computed by SwissADME) | 4 |
Rotatable Bonds(Computed by SwissADME) | 4 |
GI Absorption(Computed by SwissADME) | High |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | No |
P-gp Substrate(Computed by SwissADME) | No |
CYP1A2 Inhibitor(Computed by SwissADME) | Yes |
CYP2C19 Inhibitor(Computed by SwissADME) | No |
CYP2C9 Inhibitor(Computed by SwissADME) | No |
CYP2D6 Inhibitor(Computed by SwissADME) | No |
CYP3A4 Inhibitor(Computed by SwissADME) | Yes |
log Kp(Skin Permeation)(Computed by SwissADME) | -6.05 |
Lipinski(Computed by SwissADME) | 0 |
Ghose(Computed by SwissADME) | 0 |
Veber(Computed by SwissADME) | 0 |
Egan(Computed by SwissADME) | 0 |
Muegge(Computed by SwissADME) | 0 |
Bioavailability Score(Computed by SwissADME) | 0.55 |